tert-Butyl 3-(hydroxymethyl)-2-oxa-7-azaspiro[4.5]decane-7-carboxylate

Catalog No.: 
ACJGHP902
CAS No.: 
1251002-30-8
Molecular Formula: 
C14H25NO4
Molecular Weight: 
271.36
tert-Butyl 3-(hydroxymethyl)-2-oxa-7-azaspiro[4.5]decane-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$253.00InquiryInquiry
250mg95%$370.00InquiryInquiry
1g95%$894.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(hydroxymethyl)-2-oxa-7-azaspiro[4.5]decane-7-carboxylate
IUPAC Nametert-butyl 3-(hydroxymethyl)-2-oxa-7-azaspiro[4.5]decane-7-carboxylate
MDL No.MFCD15530243
Molecular FormulaC14H25NO4
Molecular Weight271.36
SMILESO=C(N(CCC1)CC21CC(CO)OC2)OC(C)(C)C
InChI KeyQFZWHSBESNSOMV-UHFFFAOYSA-N
SynonymTert-Butyl 3-(Hydroxymethyl)-2-Oxa-7-Azaspiro[4.5]Decane-7-Carboxylate;Tert-Butyl 3-(Hydroxymethyl)-2-Oxa-7-Azaspiro[4.5]Decane-7-Carboxylate(WX100262)
CAS No.1251002-30-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJGHP902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJGHP902 route product structure diagram
    ACJGHP9021251002-30-8
Inquiry

2. ACJGHP902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJGHP902 route product structure diagram
    ACJGHP9021251002-30-8
Inquiry

3. ACJGHP902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJGHP902 route product structure diagram
    ACJGHP9021251002-30-8
Inquiry

Comments (0)